FEDERAL COURT OF AUSTRALIA
Sanofi v Amgen Inc. (No 2) [2023] FCA 1156
File number: NSD 876 of 2022 Judgment of: YATES J Date of judgment: 22 September 2023 Date of publication of reasons: 27 September 2023 Catchwords: PRACTICE AND PROCEDURE – patents – appeal from decision of a delegate of the Commissioner of Patents in opposition proceedings – application seeking orders pursuant to r 5.04 of the Federal Court Rules 2011 (Cth) limiting evidence to be relied on at the hearing of the appeal – where respondent intends to tender declarations relied on before the delegate together with affidavits made by the same declarants – where the affidavits summarise statements made in the declarations Legislation: Evidence Act 1995 (Cth) ss 135, 136
Federal Court Rules 2011 (Cth) rr 5.04, 34.31
Patents Act 1990 (Cth) s 160
Patents Regulations 1991 (Cth) reg 5.23
Cases cited: Novartis AG v Pharmacor Pty Ltd [2022] FCAFC 58; 290 FCR 345 Division: General Division Registry: New South Wales National Practice Area: Intellectual Property Sub-area: Patents and associated Statutes Number of paragraphs: 43 Date of hearing: 21 September 2023 Counsel for the Applicant: Mr D Shavin KC and Ms K Beattie Solicitor for the Applicant: Jones Day Counsel for the Respondent: Mr T Cordiner KC and Ms M McGrath Solicitor for the Respondent: Wrays Lawyers Pty Ltd ORDERS
NSD 876 of 2022 BETWEEN: SANOFI
Applicant
AND: AMGEN INC.
Respondent
ORDER MADE BY:
YATES J
DATE OF ORDER:
22 SEPTEMBER 2023
THE COURT ORDERS THAT:
1.The interlocutory application dated 1 September 2023 be dismissed.
2.The applicant pay the respondent’s costs of and incidental to the interlocutory application.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
REASONS FOR JUDGMENT
YATES J:
INTRODUCTION
By an interlocutory application dated 1 September 2023, the applicant, Sanofi, who is the appellant in the principal proceeding, seeks orders pursuant to r 5.04 of the Federal Court Rules 2011 (Cth) (the Rules) limiting the evidence which the respondent, Amgen Inc., can adduce at the hearing of this proceeding.
The proceeding is an appeal from a decision of a delegate of the Commissioner of Patents (the delegate) in opposition proceedings. The respondent is the applicant named in Patent Application Nos. 2013203677, 2013203685, 2013203689, 2013203748, and 2013203751 (the patent applications).
The appeal is a hearing de novo in which the applicant bears the onus of making out its grounds of opposition. The applicant has raised a significant number of grounds of opposition, including an additional ground (lack of inventive step) that was not raised in the opposition before the delegate. The amended notice of appeal is complex and lengthy (79 pages).
The hearing of the proceeding is listed to commence on 6 November 2023.
BACKGROUND
The claims of the patent applications are directed to, amongst other subject matter, isolated monoclonal anti-PCSK9 antibodies that have particular features. The claims in three of the patent applications are directed to isolated monoclonal antibodies that bind…
Keep reading for free
Create a free CaseChat account to read Sanofi v Amgen Inc. (No 2) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2023] FCA 1156
- Decision Date
CaseChat Overview and Summary
The legal issue before the court was whether the respondent, Amgen Inc., could rely on affidavits that summarised the declarations of expert witnesses when the court had previously allowed both parties to rely on the declarations from the opposition proceedings. The applicant argued that the summarising of the declarations created uncertainty and potentially duplicated evidence, which they claimed was a failure to comply with the procedural orders. The court had to decide whether this constituted a breach of the orders or if it was an acceptable form of evidence presentation.
Nicholas J held that summarising the declarations in the affidavits did not amount to a failure to comply with the procedural orders. The judge noted that the affidavits could serve as context for additional evidence or as introductions for revised evidence that addressed potential admissibility objections. The judge also pointed out that if the applicant believed that the summarising raised admissibility issues, they could object at the appropriate time. Moreover, the trial judge retained the authority to manage the admissibility of evidence under the Evidence Act 1995 (Cth). The court concluded that the applicant had not demonstrated any grounds that warranted the granting of the relief sought, and the interlocutory application was dismissed with costs awarded to the respondent.
The court's decision underscored the importance of adhering to procedural orders while also allowing flexibility in evidence presentation. It highlighted that changes in the course of action based on convenience alone were insufficient to warrant a revisitation of previously granted leave. The court's ruling ensured that the proceedings would continue with the experts participating in their respective discussions, preparing a joint report to clarify areas of agreement and disagreement.
Orders
Orders of the court
1. The interlocutory application dated 1 September 2023 be dismissed.
2. The applicant pay the respondent’s costs of and incidental to the interlocutory application.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
This leads to the applicant’s second complaint which is that, in their respective affidavits, Professor Petsko, Professor Lopez, and Professor Hudson adopt the technique of “summarising” statements made in their declarations. The applicant contends that, by preparing affidavits in this form, the respondent has disregarded the orders made on 30 November 2022 and created “real uncertainty” as to the evidence on which it relies. According to the applicant, there is a “disconformity” between the declarations and the affidavits because: (a) some declarations are not referred to in some affidavits; (b) some affidavits do not address some matters addressed in the declarations; and (c) some affidavits do not respond to the applicant’s evidence where the declarations do respond to that evidence. The applicant contends that, by summarising aspects of the declarations, the deponents have “duplicated” or “recast” their evidence leaving it uncertain as to whether the summary, or the part of the declaration said to have been summarised, stands as the deponent’s evidence. The applicant submits that this is embarrassing because it does not know which part of the respondent’s evidence it is required to respond to.CONSIDERATION I am not persuaded that the applicant raises any matter that would warrant the granting of the relief sought in the interlocutory application. Leaving to one side the applicant’s complaint about “summarising”, the problems it now raises (if they be problems) existed at the time of the first case management hearing in November 2022. At that hearing, the question of the parties’ desire to rely on the declarations deployed in the opposition hearing before the Commissioner’s delegate was specifically addressed. The applicant made no complaint about the number of expert witnesses that would be involved, or the duplication of evidence that would arise, if leave were to be granted to the parties to rely on those declarations, even though those matters must have been obvious to the applicant at that time, especially bearing in mind that the parties had already participated in a complex and lengthy hearing before the delegate. Nicholas J was obviously mindful of the extent of the evidence before the delegate but was nevertheless persuaded by the parties that it would be appropriate to grant them leave to rely on that evidence. This step has set the pattern for the filing of evidence in this appeal. Circumstances have not changed since that time except for the applicant’s apparent change of mind as to the appropriateness of the respondent having the benefit of the leave that was granted. A change of mind, however, is not a sufficient reason to revisit the grant of leave that was made, no matter how inconvenient the applicant might find its present position to be. I am far from persuaded that, in the present case, the applicant will suffer any actual or potential prejudice by the course that has been adopted to date. Whilst economy in the number of experts is always desirable, a particular course has been taken in the present case of permitting each party to rely on all the evidence given on its behalf in the opposition before the delegate if that party so chooses, subject to proper objections as to admissibility and the availability of the declarants for cross-examination. The parties having now made their elections, I perceive no problem in the appropriate experts participating in the appropriate conclaves and discussing their views on the matters on which they have been asked to opine with a view to preparing a joint report identifying and explaining (to the extent necessary) their areas of agreement and disagreement.